• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Defining rare diseases in China.中国罕见病的定义。
Intractable Rare Dis Res. 2017 May;6(2):148-149. doi: 10.5582/irdr.2017.01009.
2
Study and analysis of the state of rare disease research in Shandong Province, China.中国山东省罕见病研究状况的研究与分析。
Intractable Rare Dis Res. 2012 Nov;1(4):161-6. doi: 10.5582/irdr.2012.v1.4.161.
3
Some perspectives on affordable healthcare systems in China.关于中国可负担医疗保健系统的一些观点。
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6155. doi: 10.1109/IEMBS.2007.4353757.
4
The definition of rare disease in China and its prospects.中国罕见病的定义及其前景。
Intractable Rare Dis Res. 2022 Feb;11(1):29-30. doi: 10.5582/irdr.2022.01034.
5
A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs.中国罕见病的拟议定义:从新型孤儿药投资回报的角度来看
Orphanet J Rare Dis. 2015 Mar 7;10:28. doi: 10.1186/s13023-015-0241-x.
6
Overview on social security system of rare diseases in China.中国罕见病社会保障制度概述。
Biosci Trends. 2019 Sep 17;13(4):314-323. doi: 10.5582/bst.2019.01209. Epub 2019 Aug 20.
7
Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research.中国应对罕见病的创新举措:国家罕见病登记系统、更大规模的临床队列研究以及与精准医学研究相结合的研究。
Intractable Rare Dis Res. 2017 Feb;6(1):1-5. doi: 10.5582/irdr.2017.01003.
8
Analysis of economic burden and its associated factors of twenty-three rare diseases in Shanghai.上海 23 种罕见病经济负担及其影响因素分析。
Orphanet J Rare Dis. 2019 Oct 22;14(1):233. doi: 10.1186/s13023-019-1168-4.
9
Orphan drug development in China - Turning challenges into opportunities.中国的孤儿药研发——化挑战为机遇。
Intractable Rare Dis Res. 2016 Nov;5(4):308-313. doi: 10.5582/irdr.2016.01025.
10
Environmental Exposure and Genetic Predisposition as Risk Factors for Asthma in China.环境暴露与遗传易感性作为中国哮喘的风险因素
Allergy Asthma Immunol Res. 2016 Mar;8(2):92-100. doi: 10.4168/aair.2016.8.2.92. Epub 2015 Aug 21.

引用本文的文献

1
Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.中国人患神经纤维瘤病 1 型的长期困扰:与健康相关的生活质量、经济和照顾者负担。
Front Public Health. 2024 Aug 21;12:1398803. doi: 10.3389/fpubh.2024.1398803. eCollection 2024.
2
How will the public health committees develop after COVID-19 pandemic in China? Exploration from mixed methods study in Pingshan District, Shenzhen.新冠疫情后中国公共卫生委员会将如何发展?来自深圳市坪山区混合方法研究的探索。
Front Public Health. 2024 Jan 17;12:1307771. doi: 10.3389/fpubh.2024.1307771. eCollection 2024.
3
Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China.国家以下层面的医疗保健社会保护是否足以保护罕见病患者?以中国为例。
Front Public Health. 2023 Jun 16;11:1198368. doi: 10.3389/fpubh.2023.1198368. eCollection 2023.
4
National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses.国家罕见病注册系统(NRDRS):中国首次全国范围的罕见病人口学分析。
Orphanet J Rare Dis. 2021 Dec 18;16(1):515. doi: 10.1186/s13023-021-02130-7.
5
Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai.上海 33 种有效治疗罕见病的人口统计学、院内分析和流行情况。
Orphanet J Rare Dis. 2021 Jun 8;16(1):262. doi: 10.1186/s13023-021-01830-4.
6
Establishing a rare diseases center: Experiences from Western China.建立罕见病中心:来自中国西部的经验。
Intractable Rare Dis Res. 2021 Feb;10(1):60-61. doi: 10.5582/irdr.2020.03091.
7
Determining the Topic Evolution and Sentiment Polarity for Albinism in a Chinese Online Health Community: Machine Learning and Social Network Analysis.确定中国在线健康社区中白化病的主题演变和情感极性:机器学习与社会网络分析
JMIR Med Inform. 2020 May 29;8(5):e17813. doi: 10.2196/17813.
8
Analysis of economic burden and its associated factors of twenty-three rare diseases in Shanghai.上海 23 种罕见病经济负担及其影响因素分析。
Orphanet J Rare Dis. 2019 Oct 22;14(1):233. doi: 10.1186/s13023-019-1168-4.
9
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.估算罕见病的累计点患病率:对孤儿药数据库的分析。
Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16.
10
Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance.患者 8 种特定罕见病的医疗服务保障:来自中国医保患者医疗服务利用国家体系的证据。
Orphanet J Rare Dis. 2019 Aug 20;14(1):204. doi: 10.1186/s13023-019-1165-7.

本文引用的文献

1
A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs.中国罕见病的拟议定义:从新型孤儿药投资回报的角度来看
Orphanet J Rare Dis. 2015 Mar 7;10:28. doi: 10.1186/s13023-015-0241-x.
2
Study and analysis of the state of rare disease research in Shandong Province, China.中国山东省罕见病研究状况的研究与分析。
Intractable Rare Dis Res. 2012 Nov;1(4):161-6. doi: 10.5582/irdr.2012.v1.4.161.
3
Rare diseases research in China: Opportunities, challenges, and solutions.中国的罕见病研究:机遇、挑战与解决方案。
Intractable Rare Dis Res. 2012 Feb;1(1):10-2. doi: 10.5582/irdr.2012.v1.1.10.
4
Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.亚洲的罕见病、孤儿药及其监管:现状与未来展望
Intractable Rare Dis Res. 2012 Feb;1(1):3-9. doi: 10.5582/irdr.2012.v1.1.3.
5
Rare diseases and legislation in China.中国的罕见病与立法
Lancet. 2010 Feb 27;375(9716):708-9. doi: 10.1016/S0140-6736(10)60240-1.

中国罕见病的定义。

Defining rare diseases in China.

作者信息

Cui Yazhou, Han Jinxiang

机构信息

Shandong Academy of Medical Science, Shandong Medical Biotechnological Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Ji'nan, China.

出版信息

Intractable Rare Dis Res. 2017 May;6(2):148-149. doi: 10.5582/irdr.2017.01009.

DOI:10.5582/irdr.2017.01009
PMID:28580219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5451750/
Abstract

China has the world's largest population of people with rare diseases. However, defining rare diseases remains a challenge in China. Over the past few decades, several definitions have been proposed but they have yet to be agreed to by all stakeholders. To overcome this impasse, a list of several rare diseases has recently been created. This rare disease list might be used in place of a prevalence-based definition, especially in healthcare policy-making.

摘要

中国是世界上罕见病患者人数最多的国家。然而,在中国,罕见病的定义仍是一项挑战。在过去几十年里,人们提出了几种定义,但尚未得到所有利益相关者的认可。为克服这一僵局,最近制定了一份包含多种罕见病的清单。这份罕见病清单可能会被用来取代基于患病率的定义,尤其是在医疗保健政策制定方面。